気管支炎治療の世界市場レポート 2024年

気管支炎治療の市場規模は近年力強く成長しています。2023年の52億5,000万米ドルから2024年には55億8,000万米ドルへと、CAGR6.2％で拡大します。過去の期間に観察された成長は、大気汚染レベルの上昇、タバコの喫煙の蔓延、呼吸器感染症の増加、環境や職業による暴露、呼吸器問題の原因となる様々なライフスタイル要因など、いくつかの要因に起因しています。

呼吸器疾患の有病率の増加が予想されることから、気管支炎治療市場の今後の成長が期待されます。呼吸器疾患は、感染症、アレルゲン、刺激物、遺伝的素因などのさまざまな要因から生じる、肺および広範な呼吸器系に影響を及ぼす状態を包含します。一般的な呼吸器疾患である気管支炎の治療には、症状の根本原因や重症度に合わせた多様なアプローチが含まれます。治療の選択肢には、抗生物質、抗炎症薬、呼吸器官の気道を開くように設計された気管支拡張薬などがあります。2023年6月、オーストラリア保健福祉研究所（Australian Institute of Health and Welfare）の報告によると、オーストラリアにおける呼吸器疾患関連死が増加し、2021年には46,551人に達することが明らかになった。さらにLancet誌のデータでは、2021年夏に呼吸器合胞体ウイルス（RSV）の新規患者が9.50％増加しました。これらの調査結果は、気管支炎治療市場における呼吸器系疾患の罹患率増加の原動力を強調するものです。

2023年の気管支炎治療市場で最大の地域は北米でした。気管支炎治療市場レポートの対象地域は、アジア太平洋,西欧,東欧,北米,南米,中東,アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 気管支炎治療市場の特徴

第3章 気管支炎治療市場の動向と戦略

第4章 気管支炎治療市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の気管支炎治療市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 気管支炎治療市場セグメンテーション

• 世界の気管支炎治療市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 急性気管支炎
• 慢性気管支炎
• 世界の気管支炎治療市場、治療別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 薬物
• 酸素療法
• 世界の気管支炎治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• オンライン医薬品ストア
• 小売薬局
• 病院薬局

第7章 気管支炎治療市場の地域および国分析

• 世界の気管支炎治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の気管支炎治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋の気管支炎治療市場

第9章 中国の気管支炎治療市場

第10章 インドの気管支炎治療市場

第11章 日本の気管支炎治療市場

第12章 オーストラリアの気管支炎治療市場

第13章 インドネシアの気管支炎治療市場

第14章 韓国の気管支炎治療市場

第15章 西欧の気管支炎治療市場

第16章 英国の気管支炎治療市場

第17章 ドイツの気管支炎治療市場

第18章 フランスの気管支炎治療市場

第19章 イタリアの気管支炎治療市場

第20章 スペインの気管支炎治療市場

第21章 東欧の気管支炎治療市場

第22章 ロシアの気管支炎治療市場

第23章 北米の気管支炎治療市場

第24章 米国の気管支炎治療市場

第25章 カナダの気管支炎治療市場

第26章 南米気管支炎治療市場

第27章 ブラジルの気管支炎治療市場

第28章 中東の気管支炎治療市場

第29章 アフリカの気管支炎治療市場

第30章 気管支炎治療市場の競合情勢と企業プロファイル

• 気管支炎治療市場の競合情勢
• 気管支炎治療市場の企業プロファイル
  • AstraZeneca PLC
  • Novartis AG
  • GlaxoSmithKline plc
  • Dr. Reddy's Laboratories
  • Melinta Therapeutics LLC

第31章 世界の気管支炎治療市場の競合ベンチマーキング

第32章 世界の気管支炎治療市場競争ダッシュボード

第33章 気管支炎治療市場における主要な合併と買収

第34章 気管支炎治療市場の将来展望と可能性分析

第35章 付録

“Bronchitis Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bronchitis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bronchitis treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The bronchitis treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Type: Acute Bronchitis; Chronic Bronchitis
• 2) By Treatment: Drugs; Oxygen Therapy
• 3) By Distribution Channel: Online Pharmaceutical Stores; Retail Pharmacies; Hospital Pharmacies
• Companies Mentioned: AstraZeneca PLC; Novartis AG; GlaxoSmithKline plc; Dr. Reddy's Laboratories; Melinta Therapeutics LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Bronchitis treatment involves addressing the inflammation of the bronchial tubes, which results in excessive mucus production. Medications used for this treatment include bronchodilators, steroids, and antibiotics to alleviate symptoms.

The treatment is designed to address both acute and chronic bronchitis, utilizing various approaches such as medications and oxygen therapy. Acute bronchitis is a contagious viral infection leading to inflammation in the bronchial tubes. These treatments are typically available through diverse distribution channels such as online pharmaceutical stores, retail pharmacies, and hospital pharmacies.

The bronchitis treatment market research report is one of a series of new reports from The Business Research Company that provides bronchitis treatment market statistics, including bronchitis treatment industry global market size, regional shares, competitors with a bronchitis treatment market share, detailed bronchitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the bronchitis treatment industry. This bronchitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bronchitis treatment market size has grown strongly in recent years. It will grow from $5.25 billion in 2023 to $5.58 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth observed in the historical period can be attributed to several factors, including the escalation of air pollution levels, the widespread epidemic of cigarette smoking, a rise in respiratory infections, environmental and occupational exposures, as well as various lifestyle factors contributing to respiratory issues.

The bronchitis treatment market size is expected to see strong growth in the next few years. It will grow to $7.27 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. Anticipated growth in the upcoming period can be attributed to several factors, including advancements in respiratory medicine, increased access to vaccination, customized treatment approaches for pediatric patients, the implementation of precision medicine in respiratory care, and global initiatives aimed at reducing smoking prevalence. Key trends expected in the forecast period encompass personalized treatment approaches tailored to individual patients, advancements in inhalation therapies, the development of targeted therapies catering to specific types of bronchitis, a focus on prevention strategies including vaccination, and the adoption of patient-centric care models in respiratory healthcare.

The anticipated rise in the prevalence of respiratory diseases is expected to drive the growth of the bronchitis treatment market in the future. Respiratory diseases encompass conditions affecting the lungs and the broader respiratory system, stemming from various factors such as infections, allergens, irritants, and genetic predispositions. The treatment for bronchitis, a common respiratory ailment, involves diverse approaches tailored to the specific root cause and severity of the condition. Treatment options include antibiotics, anti-inflammatories, and bronchodilators designed to open the airways of respiratory organs. Notably, in June 2023, reports from the Australian Institute of Health and Welfare revealed an increase in respiratory disease-related deaths in Australia, reaching 46,551 in 2021. Additionally, data from The Lancet indicated a 9.50% rise in new cases of respiratory syncytial virus (RSV) during the summer of 2021. These findings underscore the driving force of the growing incidence of respiratory diseases on the bronchitis treatment market.

The growing aging population is poised to contribute to the expansion of the bronchitis treatment market. The aging population phenomenon, characterized by an increasing proportion of elderly individuals within a population, presents a demographic shift with implications for healthcare. Bronchitis treatment in the elderly offers various advantages, addressing both acute and chronic forms of the condition. Benefits include symptom alleviation, complication prevention, improved respiratory function, enhanced ease of breathing, elevated overall quality of life, and reduced hospitalization risks. Globally, the World Health Organization projects that by 2030, 1 in 6 people will be aged 60 or older, with the number doubling to 2.1 billion individuals by 2050. In the UK, the House of Commons Library forecasts a 24% rise in the senior population, reaching 17.4 million people by 2043. The increasing aging population emerges as a significant driver for the growth of the bronchitis treatment market.

A prominent trend gaining traction in the bronchitis treatment market is product innovation, with major companies adopting new technologies to bolster their market standing. Notably, in June 2021, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, introduced the first generic version of PERFOROMIST®, a formoterol fumarate inhalation solution. This innovative solution targets bronchoconstriction in individuals with chronic obstructive pulmonary disease (COPD), encompassing chronic bronchitis and emphysema. Adults with COPD can manage their symptoms using this long-acting beta2-adrenergic agonist (LABA) delivered through a nebulizer. The introduction of such advanced products highlights the significance of product innovations in sustaining competitiveness within the bronchitis treatment market.

Leading companies in the bronchitis treatment market are strategically emphasizing innovative products such as arformoterol tartrate to enhance their market revenues. Arformoterol tartrate is a medication designed for treating bronchoconstriction in individuals with emphysema and chronic bronchitis, specifically those diagnosed with chronic obstructive pulmonary disease (COPD). Lupin Limited, an India-based pharmaceutical company, exemplifies this strategy by launching arformoterol tartrate in June 2021. As a bronchodilator belonging to the long-acting beta-agonist (LABA) medication class, it functions by inducing relaxation in the muscles surrounding the airways, facilitating improved breathing. Administered through nebulization, this inhalation solution is typically used twice daily - in the morning and evening.

In January 2022, Covis Pharma Group, a Switzerland-based specialty pharmaceutical company, made a strategic move by acquiring the respiratory portfolio of two medicines from AstraZeneca for $270 million. This transaction involved the acquisition of Eklira and Duaklir, positioning Covis to offer a comprehensive range of best-in-class treatments for allergic rhinitis, asthma, and chronic obstructive pulmonary disease (COPD). The acquisition underscores Covis Pharma Group's capability to collaborate effectively and become a preferred partner for major pharmaceutical firms. AstraZeneca PLC, a UK-based pharmaceutical and biotechnology company and a co-developer of a vaccine against bronchiolitis, is the other party involved in this significant transaction. This strategic initiative demonstrates the ongoing efforts of major companies to expand their product portfolios and strengthen their positions in the competitive bronchitis treatment market.

Major companies operating in the bronchitis treatment market report are AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Dr. Reddy's Laboratories, Melinta Therapeutics LLC, Sanofi S.A., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Cipla Inc., Merck and Co. Inc., Bayer AG, Johnson & Johnson Private Limited, Viatris Inc., Lupin Ltd., Cadila Healthcare Limited, Lincoln Pharmaceuticals Ltd., Nephron Pharmaceuticals Corporation, Apotex Inc., Mylan N.V., Eli Lilly and Company, AbbVie, Hetero Healthcare Ltd., Torrent Pharmaceuticals Ltd., Glenmark Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alkem Laboratories Ltd., Wockhardt Ltd

North America was the largest region in the bronchitis treatment market in 2023. The regions covered in the bronchitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the bronchitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bronchitis treatment market includes revenues earned by entities by providing vaccines surgery, and pulmonary rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Bronchitis Treatment Market Characteristics

3. Bronchitis Treatment Market Trends And Strategies

4. Bronchitis Treatment Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Bronchitis Treatment Market Size and Growth

• 5.1. Global Bronchitis Treatment Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Bronchitis Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Bronchitis Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Bronchitis Treatment Market Segmentation

• 6.1. Global Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Acute Bronchitis
• Chronic Bronchitis
• 6.2. Global Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Drugs
• Oxygen Therapy
• 6.3. Global Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Online Pharmaceutical Stores
• Retail Pharmacies
• Hospital Pharmacies

7. Bronchitis Treatment Market Regional And Country Analysis

• 7.1. Global Bronchitis Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Bronchitis Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Bronchitis Treatment Market

• 8.1. Asia-Pacific Bronchitis Treatment Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Bronchitis Treatment Market

• 9.1. China Bronchitis Treatment Market Overview
• 9.2. China Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Bronchitis Treatment Market

• 10.1. India Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Bronchitis Treatment Market

• 11.1. Japan Bronchitis Treatment Market Overview
• 11.2. Japan Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Bronchitis Treatment Market

• 12.1. Australia Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Bronchitis Treatment Market

• 13.1. Indonesia Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Bronchitis Treatment Market

• 14.1. South Korea Bronchitis Treatment Market Overview
• 14.2. South Korea Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Bronchitis Treatment Market

• 15.1. Western Europe Bronchitis Treatment Market Overview
• 15.2. Western Europe Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Bronchitis Treatment Market

• 16.1. UK Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Bronchitis Treatment Market

• 17.1. Germany Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Bronchitis Treatment Market

• 18.1. France Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Bronchitis Treatment Market

• 19.1. Italy Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Bronchitis Treatment Market

• 20.1. Spain Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Bronchitis Treatment Market

• 21.1. Eastern Europe Bronchitis Treatment Market Overview
• 21.2. Eastern Europe Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Bronchitis Treatment Market

• 22.1. Russia Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Bronchitis Treatment Market

• 23.1. North America Bronchitis Treatment Market Overview
• 23.2. North America Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Bronchitis Treatment Market

• 24.1. USA Bronchitis Treatment Market Overview
• 24.2. USA Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Bronchitis Treatment Market

• 25.1. Canada Bronchitis Treatment Market Overview
• 25.2. Canada Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Bronchitis Treatment Market

• 26.1. South America Bronchitis Treatment Market Overview
• 26.2. South America Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Bronchitis Treatment Market

• 27.1. Brazil Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Bronchitis Treatment Market

• 28.1. Middle East Bronchitis Treatment Market Overview
• 28.2. Middle East Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Bronchitis Treatment Market

• 29.1. Africa Bronchitis Treatment Market Overview
• 29.2. Africa Bronchitis Treatment Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Bronchitis Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Bronchitis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Bronchitis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Bronchitis Treatment Market Competitive Landscape
• 30.2. Bronchitis Treatment Market Company Profiles
  • 30.2.1. AstraZeneca PLC
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Novartis AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. GlaxoSmithKline plc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Dr. Reddy's Laboratories
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Melinta Therapeutics LLC
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Bronchitis Treatment Market Competitive Benchmarking

32. Global Bronchitis Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Bronchitis Treatment Market

34. Bronchitis Treatment Market Future Outlook and Potential Analysis

• 34.1 Bronchitis Treatment Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Bronchitis Treatment Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Bronchitis Treatment Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer